Hannah Robinson, MD

Research Interests

Publications

• Robinson HR, Messersmith WA, Lentz RW. HER2 Positive Metastatic Colorectal Cancer. Curr. Treat. Options in Oncol. 2024; 2024; 25: 585–604.
• Lentz RW, Friedrich T, Blatchford P, Jordan K, Pitts T, Robinson HR, Davis SL, Kim SS, Leal AD, Lee MR, Waring M, Martin A, Dominguez A, Bagby SM, Hartman SJ, Eckhardt SG, Messersmith WA, Lieu CH. A phase II study of potentiation of pembrolizumab with binimetinib and bevacizumab in refractory microsatellite stable colorectal cancer. Clinical Cancer Research. 2024 Sep 3;30(17):3768-3778.
• Robinson HR, Lakritz S, Pavlick DC, Davis S, Lieu C, Eule C, Graham LS, Spiess P, Li R, Kamat A, Grivas P, Jacob JM, Bratslavsky G, Basnet A, Wong K, Murugesan K, Lin DI, Neechi A, Ross JS, Lam ET. 1950P Squamous cell carcinoma of unknown primary (SCCUP): A genomic landscape study. Annals of Oncology. 2024 September; 35(Supplement 2):S1129-1130.
• Robinson HR, Hu J, Balmaceda N, Lentz RW, Baiyee E, Leal AD, Kim SS, Messersmith WA, Lieu CH, Davis SL. Real-World Use of Anti-EGFR Therapy in Colorectal Cancer. J Clin Oncol. 2024; 42 (Number 16_suppl):3552.
• Lentz RL, Blatchford PJ, Hu J, Pitts T, van Bokhoven A, Robinson HR, Balmaceda N, Baiyee ET, Leal AD, Kim SS, Davis SL, Lieu CH, Wadlow RC, Spencer KR, Scot AJ, Boland PM, Hochster HS, Messersmith WA. Results of a phase 2 study of evorpacept (E, ALX148), cetuximab (C), and pembrolizumab (P) in patients with refractory microsatellite stable metastatic colorectal cancer (MSS CRC). J Clin Oncol. 2024; 42 (Number 16_suppl):3530.
• Robinson HR, Hu J, Balmaceda N, Lentz RW, Baiyee E, Leal AD, Kim SS, Messersmith WA, Lieu CH, Davis SL. Disparities and trends in biomarker testing in metastatic colorectal cancer. J Clin Oncol. 2024; 42 (Number 3_suppl): 29.
• Robinson HR, Davis SL, Pavlick D, Murugesan K, Wong K, Lam ET, Ross JS, Lieu CH. Comprehensive genomic profiling of squamous cell carcinoma of unknown primary presenting with liver metastases. J Clin Oncol. 2024; 42 (Number 3_suppl): 755.
• Lakritz S, Robinson HR, Eule CJ, Graham L, Spiess PE, Li R, Kamat AM, Grivas P, Jacob JM, Bratslavsky G, Basnet A, Pavlick DC, Wong KA, Lin DI, Ross JS, Lam ET. Comprehensive Genomic Profiling of Squamous Cell Carcinoma of Unknown Primary (SCCUP) Presenting with Inguinal, Pelvic and Retroperitoneal Metastases. J Clin Oncol. 2024; 42 (Number 4_suppl): 7.
• Lentz RW, Hu J, Robinson HR, Balmaceda N, Baiyee E, Leal AD, Kim SS, Davis SL, Lieu CH, Messersmith WA. Real-world analysis of irinotecan (iri) with or without fluorouracil (5FU) in the 2nd line treatment of metastatic colorectal cancer (mCRC). J Clin Oncol. 2024; 42 (Number 3_suppl): 102.

Practice Locations

Specialty Information

• Medical Oncology
• Hematology and Oncology

• Cancers
• Cancers - Gastroenterologic Cancer (Colon, Stomach, Esophageal, Liver)
• Blood / Lymphatic System
• Cancers - Cancer Medicine